Ionis Pharmaceuticals | IONS - Operating Expenses


Ionis Pharmaceuticals reported $370.24M in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Agios Pharmaceuticals USD 130.77M 10.77M Mar/2026
Alnylam Pharmaceuticals USD 1.06B 160.97M Jun/2026
Arrowhead Research USD 215M 8.23M Mar/2026
Astellas Pharma JPY 455.56B 33.8B Jun/2026
BioCryst Pharmaceuticals USD 119.78M 673.63M Jun/2026
BioMarin Pharmaceutical USD 636.56M 39.61M Mar/2026
Celltrion KRW 119.22B 21.46B Mar/2026
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
Deva Holding AS TRY 1.35B 178.26M Sep/2023
Divis Laboratories Ltd INR 19.51B 660M Jun/2026
Exelixis USD 359.47M 3.28M Mar/2026
Halozyme Therapeutics USD 192.19M 18.88M Mar/2026
Ionis Pharmaceuticals USD 370.24M 6.24M Jun/2026
Kangmei Pharma CNY 1.09B 304.02M Mar/2026
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Laboratorios Farma EUR 313.62M 17.98M Dec/2023
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 21.61M 11.59M Dec/2025
Moderna USD 960M 817M Jun/2026
Nektar Therapeutics USD 49.12M 8.22M Mar/2026
Neuren Pharmaceuticals AUD 25.23M 16.54M Dec/2025
Neurocrine Biosciences USD 739.1M 139.2M Jun/2026
Novartis USD 10.2B 912M Jun/2026
Omeros USD 59.16M 20.13M Jun/2024
OPKO Health USD 175.21M 11.55M Mar/2026
Organigram Holdings CAD 69.59M 14.08M Mar/2026
Ovoca Bio EUR 173K 990K Dec/2025
Pfizer USD 85.19B 4.91B Jun/2026
Pharma Mar EUR 51.01M 8.73M Jun/2026
PTC Therapeutics USD 226.66M 19.64M Mar/2026
Qiagen NV USD 375.69M 42.85M Mar/2026
Regeneron Pharmaceuticals USD 31.71B 287.8M Jun/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Sarepta Therapeutics USD 372.37M 480.65M Mar/2026
Sartorius EUR 747.8M 9.4M Jun/2026
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Tilray USD 237.52M 17.34M Sep/2025
Ultragenyx Pharmaceutical USD 289M 16M Jun/2026
Vertex Pharmaceuticals USD 2.07B 217.1M Jun/2026
Zealand Pharma A/S 573M 202.97M Mar/2026
Zz Pientze Pharmaceu CNY 1.88B 326.34M Mar/2026